Papers
3
Total Citations
26
H-Index
3
About
Jeffrey Fabien is a radiation oncology researcher whose work has made meaningful contributions to the field of stereotactic body radiation therapy (SBRT) and stereotactic ablative radiotherapy (SABR), with a particular focus on the treatment of metastatic and recurrent gynecological malignancies. His research addresses critical clinical challenges at the intersection of precision radiotherapy and patient safety, systematically characterizing the toxicity profiles associated with robotic radiosurgery platforms. Among his most cited contributions, his 2012 investigation into hematological toxicity following robotic stereotactic body radiosurgery (12 citations) provided early clinical insight into an underappreciated side effect in a vulnerable patient population. His 2015 work on dynamic lung tumor tracking (9 citations) introduced a first-of-its-kind SBRT platform capable of high-precision ablative radiation delivery, directly addressing the risks of tumor miss and normal tissue injury in extracranial targets. Complementing this, his 2014 study on acute gastrointestinal toxicity after upper abdominal SABR in 34 women with recurrent gynecological cancers (5 citations) further refined understanding of treatment-related morbidity. Collectively, Fabien's work advances the safe clinical implementation of ablative radiotherapy techniques for complex oncological cases.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3